HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Fen Xia Selected Research
Fen Xia Research Topics
Disease
31
Neoplasms (Cancer)
12/2022 - 01/2002
9
Breast Neoplasms (Breast Cancer)
01/2017 - 10/2002
5
Peripheral Nervous System Diseases (PNS Diseases)
01/2022 - 01/2020
4
Brain Neoplasms (Brain Tumor)
12/2022 - 05/2009
4
Melanoma (Melanoma, Malignant)
01/2021 - 04/2014
4
Genomic Instability
11/2010 - 12/2002
3
Necrosis
09/2022 - 10/2010
3
Lung Neoplasms (Lung Cancer)
01/2020 - 05/2013
3
Neoplasm Metastasis (Metastasis)
01/2017 - 04/2014
2
Wounds and Injuries (Trauma)
11/2023 - 03/2020
2
Glioma (Gliomas)
01/2018 - 02/2013
2
Adenocarcinoma
12/2015 - 08/2013
1
Glioblastoma (Glioblastoma Multiforme)
12/2022
1
COVID-19
10/2022
1
Infections
10/2022
1
Aphasia (Dysphasia)
09/2022
1
Apraxias (Dyspraxia)
09/2022
1
Cognitive Dysfunction
09/2022
1
Headache (Headaches)
09/2022
1
Hypesthesia (Numbness)
09/2022
1
Lewis Lung Carcinoma
01/2022
1
Stroke (Strokes)
09/2021
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1
Ovarian Neoplasms (Ovarian Cancer)
01/2020
1
Pain (Aches)
11/2019
1
Leiomyoma (Uterine Fibroids)
11/2019
1
Postoperative Hemorrhage
11/2019
1
Margins of Excision
12/2015
1
Carcinogenesis
07/2015
1
Leukemia
07/2013
1
Status Epilepticus (Complex Partial Status Epilepticus)
10/2012
1
Liver Neoplasms (Liver Cancer)
11/2010
1
Plasmacytoma
10/2010
1
Multiple Myeloma
10/2010
1
Colonic Neoplasms (Colon Cancer)
08/2010
1
Hypersensitivity (Allergy)
05/2010
1
Chromosome Breakage
11/2008
1
Ataxia Telangiectasia (Louis Bar Syndrome)
07/2007
Drug/Important Bio-Agent (IBA)
7
Proteins (Proteins, Gene)
FDA Link
01/2017 - 10/2002
6
Cisplatin (Platino)
FDA Link
Generic
01/2022 - 08/2010
6
1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)
IBA
11/2018 - 01/2002
5
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2020 - 05/2010
5
DNA (Deoxyribonucleic Acid)
IBA
11/2018 - 01/2004
4
Sirtuin 2
IBA
01/2022 - 01/2020
4
Platinum
IBA
07/2021 - 01/2020
3
Biomarkers (Surrogate Marker)
IBA
12/2015 - 08/2013
3
Small Interfering RNA (siRNA)
IBA
11/2010 - 07/2007
2
Solutions
IBA
11/2023 - 10/2022
2
Methionine (L-Methionine)
FDA Link
01/2020 - 01/2018
2
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
01/2020 - 11/2012
2
Interleukin-6 (Interleukin 6)
IBA
11/2019 - 01/2017
2
Pyruvate Kinase
IBA
11/2018 - 12/2015
1
Sodium
IBA
12/2022
1
Anticonvulsants (Antiepileptic Drugs)
IBA
12/2022
1
Calcium
IBA
12/2022
1
nicotinamide-beta-riboside
IBA
01/2022
1
NAD (NADH)
IBA
01/2021
1
Histone Deacetylases (Histone Deacetylase)
IBA
01/2021
1
Antioxidants
IBA
11/2019
1
Protein Isoforms (Isoforms)
IBA
11/2018
1
Sorafenib (BAY 43-9006)
FDA Link
06/2017
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
01/2017
1
STA 9090
IBA
01/2017
1
Estrogen Receptors
IBA
01/2017
1
veliparib
IBA
01/2017
1
Isoenzymes
IBA
12/2015
1
Enzymes
IBA
12/2015
1
Vemurafenib
IBA
04/2014
1
Estrogen Receptor alpha
IBA
07/2013
1
Histones (Histone)
IBA
07/2013
1
Histone Methyltransferases
IBA
07/2013
1
Chromatin
IBA
11/2010
1
Messenger RNA (mRNA)
IBA
11/2010
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2008
1
ErbB Receptors (EGF Receptor)
IBA
11/2008
1
Protein Kinases (Protein Kinase)
IBA
07/2007
1
Single-Stranded DNA (DNA, Single Stranded)
IBA
12/2002
1
BRCA2 Protein
IBA
12/2002
1
Ataxia Telangiectasia Mutated Proteins
IBA
10/2002
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
10/2002
Therapy/Procedure
15
Therapeutics
09/2022 - 10/2002
11
Drug Therapy (Chemotherapy)
09/2022 - 01/2002
5
Radiotherapy
12/2022 - 10/2010
4
Drug Tapering
02/2021 - 01/2020
2
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
09/2022 - 05/2018
1
Mechanical Ventilators (Ventilator)
10/2022
1
Overlapping Surgery
09/2022
1
Retreatment
09/2022
1
Length of Stay
11/2019
1
Uterine Myomectomy
11/2019
1
Adjuvant Chemotherapy
12/2015
1
Molecular Targeted Therapy
05/2013
1
Cranial Irradiation
05/2009